IgG Glyco-Engineering to Improve IVIg Potency

Intravenous immunoglobulins (IVIg) are used in the treatment of different autoimmune and inflammatory diseases, such as immune thrombocytopenia and hemolytic anemia. One of the modes of action of IVIg is preventing phagocytosis of autoantibody-opsonized blood cells by saturation of the Fc-gamma rece...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Immunol
Main Authors: Bruggeman, Christine W., Dekkers, Gillian, Visser, Remco, Goes, Naneth W. M., van den Berg, Timo K., Rispens, Theo, Vidarsson, Gestur, Kuijpers, Taco W.
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2018
Teme:
Immunology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6206079/
https://ncbi.nlm.nih.gov/pubmed/30405631
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.02442
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki